AYTU

Q: What is the price of Aytu Biopharma (AYTU) today?

The price of Aytu Biopharma (AYTU) today is US$ 2,36, with a variation of 0.85% compared to the last year. The price of Aytu Biopharma (AYTU) started the year trading around US$ 1,70 and today it is at US$ 2,36. Follow the real-time price chart, the historical price of Aytu Biopharma (AYTU), and stock data from Ibovespa and international markets.

Q: When does Aytu Biopharma (AYTU) pay dividends?

Aytu Biopharma (AYTU) did not distribute dividends in the last year.

Q: Aytu Biopharma (AYTU) is it worth it?

Currently, Aytu Biopharma (AYTU) is priced at US$ 2,36, with a P/E of -0,98%, representing a deviation of -2,10% from its historical average P/E. In the last year, the stock showed a variation of 0.85% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 0,85%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Aytu Biopharma (AYTU)?

Investing in stocks of Aytu Biopharma (AYTU) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Aytu Biopharma (AYTU) yield today?

The yield of Aytu Biopharma (AYTU) was 4,42% in the last month, 0,85% in the last year and -98,96% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of Aytu Biopharma (AYTU) today, the total investment would be US$ 236,00, based on the current price of US$ 2,36.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 238,01In 5 years: US$ 2,45In 10 years: 236,00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Aytu Biopharma Inc.

Price

US$ 2,36

variation (12m)

0,85%

p/l

-0,98

p/vp

0,70

DIVIDEND YIELD

0,00%

price AYTU

BVMF

AYTU

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of AYTU

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

4,42%

3 months

0,00%

1 year

0,85%

2 years

-18,90%

5 years

-98,96%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

4,42%

3 months

0,00%

1 year

-3,11%

2 years

-25,62%

5 years

-99,23%

10 years

0,00%

Indicators AYTU

check out the fundamentals of Aytu Biopharma shares

P/E

-0,98

Sector: -1,19 Industry: 20,33

P/SALES RATIO (PSR)

0,20

Sector: 1,95 Industry: 3,14

P/BV

0,70

Sector: 2,22 Industry: 3,50

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

-10,93%

Sector: -26,82% Industry: -7,76%

ROE

-71,53%

Sector: -29,98% Industry: -17,55%

ROIC

3,45%

Sector: -411,56% Industry: -13,92%

NET MARGIN

-20,45%

Sector: -27,32% Industry: -26,93%

GROSS MARGIN

69,05%

Sector: 43,14% Industry: 51,86%

OPERATING MARGIN

3,81%

Sector: -23,36% Industry: -20,56%

P/EBITDA

-2,85

Sector: 0,02 Industry: 8,21

P/EBIT

-1,32

Sector: -1,26 Industry: 7,15

P/ASSET

0,11

Sector: 1,27 Industry: 1,28

BVPS

2,71

Sector: 3,73 Industry: 8,92

EPS

-1,94

Sector: -0,77 Industry: -0,02

EQUITY / ASSETS

0,15

Sector: 0,45 Industry: 0,45

CAGR REVENUES 5 YEARS

3,07%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-8,61%

Sector: - Industry: -

AYTU indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
LLY	54,65	41,10	75,21%	0,69%	US$ 754,20 B	25,91%
ISRG	60,13	9,05	15,04%	0,00%	US$ 162,39 B	28,29%
TMO	31,25	4,06	12,99%	0,30%	US$ 205,37 B	15,12%
SNY	7,88	1,54	19,52%	4,35%	US$ 124,76 B	22,40%
MDT	26,88	2,60	9,68%	2,88%	US$ 125,25 B	13,63%
CVS	17,95	1,27	7,05%	3,43%	US$ 98,10 B	1,40%
GSK	13,33	4,47	33,57%	3,74%	US$ 87,13 B	15,70%
NVS	17,78	6,13	34,49%	2,92%	US$ 257,90 B	25,52%
ABT	16,70	4,59	27,50%	1,73%	US$ 233,46 B	32,43%
BSX	50,82	6,36	12,51%	0,00%	US$ 144,03 B	14,65%
TMDX	38,43	12,37	32,18%	0,00%	US$ 3,93 B	17,65%
HCA	16,16	-82,92	-513,25%	0,66%	US$ 102,66 B	8,61%
DHR	48,94	2,95	6,02%	0,55%	US$ 154,15 B	13,04%
INMD	6,18	1,52	24,58%	0,00%	US$ 954,45 M	42,09%
IDXX	48,24	34,61	71,76%	0,00%	US$ 50,50 B	25,09%
FMS	20,85	0,95	4,56%	2,94%	US$ 15,70 B	3,48%
PHG	92,60	2,21	2,38%	3,16%	US$ 26,49 B	1,45%
HUM	20,85	1,87	8,97%	1,25%	US$ 34,21 B	1,30%
RMD	27,69	6,82	24,62%	0,79%	US$ 40,67 B	27,88%